Clinical Trial: Single-Cell Profiling of Liver-infiltrating Immune Cells of Patients with NASH- and Virus-related HCC: Implications for Immunotherapy

U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06899763) titled 'Single-Cell Profiling of Liver-infiltrating Immune Cells of Patients with NASH- and Virus-related HCC: Implications for Immunotherapy' on March 21.

Brief Summary: The goal of this observational study is to learn about the the immune landscape of HCC arising from different etiology, such as MASLD and viral hepatitis, at single cell level. The main question it aims to answer is:

Which are the immune signatures and pathways linked to MASLD- or virus-related HCC and what could be the best targets for immunotherapy?

Study Start Date: Jan. 01, 2023

Study Type: OBSERVATIONAL

Condition: Hepatocellular Carcinoma (HCC) MASLD-HCC HCV_HCC...